[1]肖亚雄,彭宇生,王 鹏,等.生物梅里埃ATB STAPH 5葡萄球菌药敏试剂盒的局限性分析[J].现代检验医学杂志,2015,30(03):122-125.[doi:10.3969/j.issn.1671-7414.2015.03.037]
　XIAO Ya-xiong,PENG Yu-sheng,WANG Peng,et al.Limitation of Staphylococcus Spp Test Kit ATB STAPH 5 from BioMerieux in Clinical Applcation[J].Journal of Modern Laboratory Medicine,2015,30(03):122-125.[doi:10.3969/j.issn.1671-7414.2015.03.037]
点击复制

生物梅里埃ATB STAPH 5葡萄球菌药敏试剂盒的局限性分析()
分享到：

《现代检验医学杂志》[ISSN:/CN:]

卷:
第30卷
期数:
2015年03期
页码:
122-125
栏目:
研究简报·实验技术
出版日期:
2015-06-10

文章信息/Info

Title:
Limitation of Staphylococcus Spp Test Kit ATB STAPH 5 from BioMerieux in Clinical Applcation
文章编号:
1671-7414(2015)03-122-04
作者:
肖亚雄; 彭宇生; 王 鹏; 黄忠团; 代小琴
宜宾市第一人民医院检验科,四川宜宾 644600
Author(s):
XIAO Ya-xiong; PENG Yu-sheng; WANG Peng; HUANG Zhong-tuan; DAI Xiao-qin
Department of Clinical Laboratory,the First People's Hospital of Yibin City,Sichuan Yibin 644600,China
关键词:
生物梅里埃;  药敏;  葡萄球菌;  局限性
分类号:
R446.5
DOI:
10.3969/j.issn.1671-7414.2015.03.037
文献标志码:
A
摘要:
目的 分析探讨生物梅里埃产葡萄球菌药敏试剂盒ATB STAPH 5在临床运用中存在的缺陷,并提出补救/解决方案。方法 以CLSIM100-S23提供的葡萄球菌对应抗生素拐点作为标准,对梅里埃药敏试剂盒ATB STAPH 5抗生素覆盖情况与各抗生素拐点浓度进行对比分析。结果 ATB STAPH5试剂盒不包括CLSI推荐的氯霉素类和恶唑烷酮类、脂肽类三类抗生素; ATB STAPH 5试剂盒提供的16种抗生素拐点均与CLSI M100-S23 推荐抗生素拐点不一致,从而可能导致临床药敏报告出现假敏感或假耐药的情况。结论 在现行CLSI参考标准下,单独使用ATB STAPH 5试剂盒进行葡萄球菌药敏试验将产生较大误差甚至错误,必须要其他药敏试验方法进行修正方可发出报告。
Abstract:
Objective To study the limitation analysis ofStaphylococcus spp Susceptibility Test Kit ATB STAPH 5 from BioMerieux in clinical application and to propose remedy.Methods The coverage area and break point of antibiotics ATB STAPH 5 from BioMerieux were analysed by using CLSI M100-S23 as standard.Results The kitATB STAPH 5 did not include chloromycetin,oxazolidinones and lipopeptide threeantibiotics that were recommend by CLSI.The 16 kinds of antibiotics break point in the kit ATB STAPH 5 were all not inconsistent or did not contain with the standard of CLSI M100-S23.It may lead to error drug sensitivity tests,false sensitive or false drug resistance.Conclusion Only using this kit ATB STAPH 5 for Staphylococcus spp,it may occurre errors or mistakes.Other experiments must be corrected before the report.

参考文献/References:

[1] 中华检验医学杂志CLSI临床检验标准编译小组.抗菌药物敏感性试验执行标准.第二十三版资料增刊[S].中华检验医学杂志(CLSI文件M100-S23),2013:72-82.
Chin J Lab Med CLSI Clinical laboratory standard compilation group.Performance standards for antimicrobial susceptibility testing.twenty-third Informational supplement[S].Chin J Lab Med(CLSI Document M100-S23),2013:72-82.
[2] 黎村艳,曹友德,蔡瑞云,等.1 296株革兰阳性球菌的分布和耐药性分析[J].中国病原生物学杂志,2013,8(1):76-79.
Li CY,Cao YD,Cai RY,et al.Analysisi of the clinical distribution and drug resistance of 1 296 strains of Gram-positive cocci[J].Journal ofPathogen Biology,2013,8(1):76-79.
[3] 凌宙贵,刘 滨,刘 卫,等.2009～2011年革兰阳性球菌分布及耐药性监测分析[J].中华医院感染学杂志,2013,23(24):6109-6111.
Ling ZG,Liu B,Liu W,et al.Distribution and drug resisitance of gram-positive cocci during 2009～2011[J].Chin J Nosocomiol,2013,23(24):6109-6111.
[4] 贾方增,郑小涛,陈统献,等.不同病区金黄色葡萄球菌的耐药性及mecA基因携带差异研究[J].中华医院感染学杂志,2014,24(7):1567-1569.
Jia FZ,Zheng XT,Chen TX,et al.Resistance of Staphylococcus aureus isolated from different wards and analysis on the difference in mecA genecarrying[J].Chin J Nosocomiol,2014,24(7):1567-1569.
[5] Mezzatesta ML,Caio C,Gona F,et al.Carbapenem and multidrug resistancein Gram-negative bacteria in a single centre in Italy:Considerations on in vitro assay of active drugs[J].Int J Antimicrob Agents,2014,44(2):112-116.
[6] 归巧娣,苍金荣,刘 英.2010～2012年血培养病原菌分布及耐药性分析[J].现代检验医学杂志,2013,28(5):165-166.
Gui QD,Cang JR,Liu Y.Distribution and drug resisitance of pathogens from blood culture samples 2010～2012[J].J Mod Lab Med,2013,28(5):165-166.
[7] 李 珍,李从荣,蔡 璇,等.武汉地区泌尿道感染病原菌的分布及耐药性分析[J].现代检验医学杂志,2014,29(5):135-137.
Li Z,Li CR,Cai X,et al.Analysis of clinical distribution and Drugresistance of pothogen in urinary tract infection in Wuhan[J].J Mod Lab Med,2014,29(5):135-137.
[8] 伍娟英,张 斌,姜 熙,等.329例尿路感染常见细菌分布及耐药性分析[J].检验医学与临床,2014,11(9):1244-1245.
Wu JY,Zhang B,Jiang X,et al.Bacterial distribution and drug resisitance of pathogens in 329 strains of urinary tract infection[J].Lab Med Clin,2014,11(9):1244-1245.
[9] 郎耀雄,许建英,王淑峰,等.下呼吸道感染痰分离菌细菌谱及耐药性分析[J].中华医院感染学杂志,2013,23(5):1193-1195.
Lang YX,Xu JY,Wang SF,et al.Bacterial spectrum and drug resisitance of bacteria isolated from patients with lower respiratory tract infections[J].Chin J Nosocomiol,2013,23(5):1193-1195.
[10] 周 琪,李映潼,翟 宏,等.Mohnarin 2008年度报告:脓液来源细菌耐药监测[J].中国抗生素杂志,2010,35(8):625-632.
Zhou Q,Li YT,Zhai H,et al.2008 mohnarin report:bacterial distributionand resisitance in abscess infections[J].Chinese Journal of Antibiotics,2010,35(8):625-632.
[11] 王 华,苍金荣,张利侠,等.四种抗生素对西安地区耐甲氧西林金黄色葡萄球菌体外抗菌活性观察[J].现代检验医学杂志,2012,27(5):138,140.
Wang H,Cang JR,Zhang LX,et al.The antimicrobial activity of four kindsof antibiotics to methicillin-resistant Staphylococcus aureus in vitro inXi'an[J].J Mod Lab Med,2012,27(5):138,140.
[12] 田 锐,许宏涛,柳 宏,等.异质性万古霉素中介金黄色葡萄球菌在心内科病房血流感染中的研究[J].中华医院感染学杂志,2013,23(4):721-723.
Tian R,Xu HT,Liu H,et al.Study of heteroresistant vancomycin-intermediate Staphylococcus aureus in blood stream infections in cardiology department[J].Chin J Nosocomiol,2013,23(4):721-723.
[13] 刘亚丽,徐英春.异质性万古霉素中介金黄色葡萄球菌:困扰我们的难题[J].中国感染与化疗杂志,2013,13(6):495-498.
Liu YL,Xu YC.Heteroresistant vancomycin-intermediate Staphylococcus aureus:a challenge in clinical practice[J].Chin J Inffect Chemother,2013,13(6):495-498.

备注/Memo

备注/Memo:
作者简介:肖亚雄(1981-),男,硕士,主管技师,主要从事临床微生物耐药性研究,Tel:13684177400,E-mail:xiaoyaxiong@163.com。
更新日期/Last Update: 2015-06-10